Financials data is unavailable for this security.
View more
Year on year INVO Bioscience Inc grew revenues 267.38% from 822.20k to 3.02m while net income improved from a loss of 10.89m to a smaller loss of 8.03m.
Gross margin | 44.89% |
---|---|
Net profit margin | -122.80% |
Operating margin | -94.34% |
Return on assets | -57.44% |
---|---|
Return on equity | -- |
Return on investment | -116.03% |
More ▼
Cash flow in USDView more
In 2023, INVO Bioscience Inc increased its cash reserves by 157.84%, or 142.28k. Cash Flow from Financing totalled 7.39m or 244.73% of revenues. In addition the company used 4.76m for operations while cash used for investing totalled 2.49m.
Cash flow per share | -2.74 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.3529 |
---|---|
Tangible book value per share | -2.12 |
More ▼
Balance sheet in USDView more
Current ratio | 0.2999 |
---|---|
Quick ratio | 0.2686 |
Total debt/total equity | 1.93 |
---|---|
Total debt/total capital | 0.6588 |
More ▼